Qsemble Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Sell |
21,827
-21,438
| -50% | -$1.18M | 0.12% | 224 |
|
|
2025
Q1 | $3.06M | Buy |
43,265
+10,929
| +34% | +$773K | 0.32% | 114 |
|
|
2024
Q4 | $2.13M | Buy |
+32,336
| New | +$2.13M | 0.28% | 128 |
|
|
2024
Q2 | – | Sell |
-8,848
| Closed | -$773K | – | 435 |
|
|
2024
Q1 | $773K | Sell |
8,848
-960
| -10% | -$83.8K | 0.17% | 205 |
|
|
2023
Q4 | $946K | Sell |
9,808
-8,592
| -47% | -$828K | 0.24% | 160 |
|
|
2023
Q3 | $1.63M | Buy |
18,400
+7,100
| +63% | +$628K | 0.3% | 117 |
|
|
2023
Q2 | $979K | Buy |
+11,300
| New | +$979K | 0.7% | 56 |
|
|
2023
Q1 | – | Sell |
-8,100
| Closed | -$838K | – | 246 |
|
|
2022
Q4 | $838K | Buy |
+8,100
| New | +$838K | 0.58% | 60 |
|